Complex mechanisms for the packaging of the UL16 tegument protein into herpes simplex virus  by Meckes, David G. et al.
Virology 398 (2010) 208–213
Contents lists available at ScienceDirect
Virology
j ourna l homepage: www.e lsev ie r.com/ locate /yv i roComplex mechanisms for the packaging of the UL16 tegument protein into herpes
simplex virus
David G. Meckes Jr., Jacob A. Marsh, John W. Wills ⁎
Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, 500 University Drive, P.O. Box 850, Hershey, PA 17033, USA⁎ Corresponding author. Fax: +1 717 531 6522.
E-mail address: jww4@psu.edu (J.W. Wills).
0042-6822/$ – see front matter © 2009 Elsevier Inc. A
doi:10.1016/j.virol.2009.12.004a b s t r a c ta r t i c l e i n f oArticle history:
Received 22 September 2009
Returned to author for revision
19 October 2009
Accepted 2 December 2009
Available online 3 January 2010
Keywords:
Herpes simplex
UL16
Virus assembly
Capsid
HSVThe conserved UL16 tegument protein of herpes simplex virus exhibits dynamic capsid-binding properties
with a release mechanism that is triggered during initial virus attachment events. In an effort to understand
the capsid association and subsequent release of UL16, we sought to deﬁne the mechanism by which this
protein is packaged into virions. The data presented here support a model for the addition of some UL16 to
capsids prior to their arrival at the TGN. UL16 was found on capsids isolated from cells infected with viruses
lacking UL36, UL37 or gE/gD, which are defective for budding and accumulate non-enveloped capsids in the
cytoplasm. Additionally, membrane-ﬂotation experiments showed that UL16 co-puriﬁed with cytoplasmic
capsids that are not associated with membranes. Moreover, the amount of UL16 packaged into extracellular
particles was severely reduced in the absence of two conserved binding partners, UL21 or UL11.
© 2009 Elsevier Inc. All rights reserved.Introduction
The tegument of herpes viruses is comprised of an assortment of
proteins found between the viral envelope and the DNA-ﬁlled capsid.
This compartment contains more than 15 different virally encoded
proteins for which many of their functions remain unknown. Much
effort has been placed on elucidating the molecular interactions
between various tegument proteins with the hope of understanding
the mechanisms by which this complex virus is assembled (Metten-
leiter et al., 2006). Tegument addition is thought to originate in the
nucleus, then more tegument proteins are added to capsids in the
cytoplasm following nuclear egress and ﬁnally at trans-Golgi network
(TGN)-derivedmembranes during maturation budding (Mettenleiter,
2006). The goal of the experiments described here was to deﬁne
where the conserved tegument protein UL16 is packaged into the
virus particle along this assembly pathway and to determine which
protein–protein interactions may contribute.
UL16 has been shown to be present in the nucleus and cytoplasm
during an infection (Nalwanga et al., 1996); however, it has only been
detected on capsids puriﬁed from the cytoplasm (Meckes, Jr. and
Wills, 2007). Recently, we showed that UL16 has different capsid-
binding properties in the virion compared to capsids isolated from the
cytoplasm (Meckes, Jr. and Wills, 2007). Speciﬁcally, the majority of
UL16 is removed from extracellular capsids following NP40 treatment
but is bound to capsids isolated from the cytoplasm of cells using
similar lysis conditions (Meckes, Jr. and Wills, 2007). These datall rights reserved.suggest that the interaction may be changed or destabilized during
virus egress, possibly as a maturation mechanism to prepare the virus
for entry into the next cell (Meckes, Jr. and Wills, 2008).
The actual function of UL16 for any herpesvirus remains a mystery,
but it has been speculated to provide a bridging function between the
capsid and the membrane during budding events through its interac-
tionswith the capsid and themembrane-bound tegument protein UL11
(Loomis et al., 2003). UL11 is a small (∼15 kDa) myristylated and
palmitylated protein which accumulates at TGN-derived vesicles in the
absence of other viral proteins (Loomis et al., 2001). Approximately 700
molecules of UL11 are packaged into virus particles independently of its
interaction with UL16 (Loomis et al., 2006). UL16 also interacts with
another conserved tegument protein named UL21 that associates with
capsids and microtubules (de Wind et al., 1992; Takakuwa et al., 2001;
Klupp et al., 2005). These ﬁndings suggest a possible role for UL21 in
capsid transport to TGN-derived vesicles. Prior to the experiments
presented here, it seemed probable that UL16 was attached to capsids
through an interactionwith the capsid-bound UL21. Capsids containing
UL21 and UL16 could then interact with membranes through the UL11
protein. Consistent with this simple model of capsid transport and
budding, herpes viruses lackingUL16, UL21 orUL11 (or their homologs)
have defects in virus egress compared to wild-type, resulting in
decreased amounts of extracellular virus produced and the accumula-
tion of non-enveloped capsids in the cytoplasm (Baines and Roizman,
1991, 1992; Britt et al., 2004; Kopp et al., 2003, 2004; MacLean et al.,
1989, 1992; Schimmer and Neubauer, 2003; Silva et al., 2003, 2005;
Baines et al., 1994; Guo et al., 2009).
Based on the available data, there were at least three possible
mechanisms of UL16 packaging into virus particles during assembly
Fig. 1. Potential UL16 packagingmechanisms. Mature DNA-containing C-capsids exit the nucleus of infected cells via a budding then fusionmechanism across the nuclear envelope. It
is at this step during the assembly process that UL16 could be loaded onto capsids through its direct interaction with the membrane-bound UL11 protein that is present on the
nuclear envelope (nuclear-loading model). Following exit from the nucleus, non-enveloped capsids transverse the cytoplasm and provide another potential location for the
incorporation of UL16 (capsid-loading model), possibly through an interaction with the capsid-bound UL21 protein. And ﬁnally, cytoplasmic capsids reach TGN-derived membranes
where the ﬁnal budding event is orchestrated. It is here that capsids acquire additional tegument proteins and their full complement of glycoproteins. Since UL11 targets to these
membranes, it could bring UL16 to this location for packaging into virus particles (TGN-loading model).
Fig. 2. UL16 is associated with non-membrane-bound capsids. Cells were infected with
(A)HSVor (B) amutant that doesnotmake capsids (K23Z) for20handmechanically lysed
in a hypotonic buffer. Lysates were then loaded on the bottom of a sucrose step gradients
and centrifuged for 18 h to ﬂoat membranes (top) away from non-membrane-bound
proteins (bottom). Fractions (800 μl) were collected from the top of the gradient, proteins
in the fractions were then TCA-precipitated, separated by SDS–PAGE in 10% gels and
analyzed by immunoblot with antibodies speciﬁc for gE, VP5 and UL16. (C) The bottom
two non-membrane associated fractions from the gradients were incubated in NP-40
lysis buffer for 15min. Capsids in these fractionswere subsequentlypelleted througha30%
(wt/vol) sucrose cushion and analyzed by immunoblotting.
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(nuclear-loading model). In the second model, UL16 attaches to DNA-
containingC-capsids in the cytoplasmprior to their arrival at theTGN for
maturation budding (capsid-loading model). Subsequent interaction of
UL16 with UL11 would fasten capsids to the membrane and drive the
budding process. In the third mechanism of packaging, UL16 is
transported to the TGN independently of capsids, likely through an
interactionwith UL11 (TGN-loadingmodel).When capsids arrive at the
membrane, their binding toUL16–UL11complexeswould thenpromote
budding. The purpose of the experiments described here was to test
these loading models for UL16 packaging.
Results
UL16 is added to nucleocapsids prior to their arrival at the TGN
ULl6 has been shown to be associated with capsids puriﬁed from
the cytoplasm, which suggested that the capsid-loading model was a
potential mechanism of UL16 incorporation into virions (Meckes, Jr.
and Wills, 2007). However, since these capsids include ones from
cytoplasmic enveloped virions that are stripped of their membranes
by the detergent lysis conditions, it was unclear whether UL16 was
added to capsids prior to maturation budding.
To separate enveloped from non-enveloped capsids, a membrane
ﬂoatation assaywas employed following osmotic lysis of infected cells
(Baird et al., 2008). Brieﬂy, the cells were lysed by dounce
homogenization, and the cytoplasmic fraction was layered on the
bottom of a sucrose step gradient. Then, the gradients were
centrifuged for 18 h to separate membranes (and associated proteins)
from the non-membrane-bound proteins, which remain in the
bottom fractions. In this assay, enveloped virions will ﬂoat to the
top of the gradient (Baird et al., 2008), and as expected, the major
capsid protein (VP5), UL16 and glycoprotein E (gE) were found in this
fraction (Fig. 2A). If enveloped virions were trapped in the bottom
fractions, then we would expect the trans-membrane viral glycopro-
tein to be found there, but this was not the case (gE panel, bottom
fractions). VP5 and UL16 were found in the bottom fractions of the
gradient where you would expect soluble, non-membrane associated
proteins to remain during centrifugation. As a control, we analyzed
the cytoplasm of cells infected with a mutant virus that lacks the
triplex protein VP23 (designated K23Z), which does not make capsids
and therefore cannot produce enveloped particles (Desai et al., 1993).
Fig. 3. UL16 is bound to cytoplasmic capsids that are blocked in maturation budding.
Cytoplasmic capsids from detergent lysed (A) WT, ΔUL37 or gE−/gD−-infected cells
were sedimented in 20 to 50% (wt/vol) sucrose gradients for 1 h. Fractions containing
capsid bands were pulled with a needle syringe and pelleted through another 30%
sucrose cushion. Puriﬁed capsids and associated proteins were separated by SDS–PAGE
in 10% gels and analyzed by immunoblotting with anti-VP5, anti-UL37, anti-UL16, anti-
gE and anti-gD rabbit serum. (B) ΔUL36 and ΔUL37 capsids were isolated from infected
cells in parallel with WT as described above. cyto, cytoplasmic. WT, wild-type.
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fraction (Fig. 2B, VP5 panel, top fractions), a population of UL16 was
found there which implies that during an infection UL16 can associate
with membranes in the absence of capsid budding events (Fig. 2B).
This membrane association is likely due to an interaction with
membrane-bound viral proteins (e.g., UL11) since UL16 was not
detected in the ﬂoating fraction of UL16-transfected cells (data not
shown). Consistently less VP5 (and UL16) was found in the bottom-
most pellet fraction of K23Z compared to wild-type gradients (Figs. 2A
and B, rightmost lanes). This is most likely due to the inability of the
K23Z mutant virus to construct capsids, which would remain in the
bottom fraction in this assay. The overall reduced levels of VP5 in the
K23Z gradient are likely due to degradation since the protein is not
assembled into stable capsids. In contrast, the levels of gE remain the
same for both the wild-type and mutant, as expected since equal
amounts of infected cells were lysed and loaded on the bottom of each
gradient.
To analyze capsids that are not associated with membranes, we
combined the two bottom-most fractions from the sucrose gradient,
treated them with NP-40 lysis buffer and re-pelleted the capsids
through a 30% sucrose cushion. UL16 was readily found co-purifying
with non-membrane-bound cytoplasmic capsids from cells infected
withwild-type virus, but it did not pellet in the case of K23Z, for which
there is an absence of capsids (Fig. 2C). It is possible that the lysis
conditions used in these experiments could disrupt nuclei, releasing
wild-type capsids into the cytoplasmic fraction. If this were the case,
the data presented would represent an underestimate for the amount
of UL16 relative to capsids since UL16 is not found on capsids puriﬁed
from nuclei (Meckes, Jr. and Wills, 2007).
UL16 is present on capsids that are unable to perform secondary
envelopment
Although the membrane ﬂoatation experiments support the
capsid-loading model, the possibility remained that capsids may
have interacted with membranes and “fallen” off during the
disruption process. Therefore, to test the capsid-loading model with
a different approach, cytoplasmic capsids were sucrose gradient
puriﬁed from cells infected with mutant viruses that are blocked for
maturation budding (Farnsworth et al., 2003; Desai, 2000; Desai et al.,
2001). UL16 was readily detectible with capsids puriﬁed from the
cytoplasm of cells infected with gE−/gD− and UL37-null viruses (Fig.
3A, right panels). To test for the purity of the mutant virus
preparations, immunoblot analysis for gE, gD and UL37 was
performed with portions of the cell lysates (Fig. 3A, left panels) and
by comparing virus titers on complementing and non-complementing
cells (data not shown). Typically, virus titers were down three to ﬁve
logs when grown on non-complementing Vero cells. Capsids lacking
UL36, another tegument protein critical for ﬁnal envelopment, also
contained equivalent amounts of UL16 compared to WT capsids (Fig.
3B, right panels). Unfortunately, we were unable to detect the
presence of UL36 in cell lysates from wild-type or mutant virus-
infected cells by immunoblotting with a rabbit polyclonal antibody
(Bucks et al., 2007); however, the virus could only be propagated on
UL36 expressing cells (data not shown), conﬁrming that the defect in
assembly this virus exhibited was due to the absence of the UL36 gene
(Desai, 2000).
Unlike the capsids harvested from the gE−/gD− and UL36-null
viruses, which contained roughly equivalent levels of UL16 compared
to WT capsids, the amount of UL16 on ΔUL37 capsids relative to WT
was somewhat reduced (42%±33, Figs. 3A and B). This variability
may be due to the fact that the ΔUL37 virus accumulates large clusters
of capsids in the cytoplasm and nucleus of infected cells, which might
prevent them from acquiring normal amounts of tegument proteins.
However, it does remain a possibility that some UL16may be added to
capsids through an interaction with UL37 or one of its bindingpartners since in the absence of UL37, less UL16was detected on these
capsids. Taken together, these data provide further evidence that at
least some UL16 is added to capsids prior to their arrival at the TGN for
maturation budding.
UL16 is packaged independently of its interaction with UL11 or UL21
UL16 is a direct binding partner of the conserved tegument protein
UL11 (Yeh et al., 2008; Lee et al., 2008; Vittone et al., 2005; Loomis et
al., 2003). During our work on the UL11-UL16 interaction in HSV, an
additional 65-kDa protein consistently puriﬁed with these proteins
(Loomis et al., 2003), and it has been identiﬁed as UL21 by mass
spectrometry. Detailed studies have shown that UL16 directly
interacts with UL21 (Harper et al., unpublished results). To ascertain
the importance of UL11 and UL21 for UL16 packaging, mutant viruses
lacking their individual genes where analyzed.
Based on published results deﬁning UL21 as a capsid-bound
protein (de Wind et al., 1992), it was anticipated that this protein
might link UL16 to capsids. However, when capsids were puriﬁed
from cells infected with a UL21-null virus, UL16 was detected at
equivalent levels compared to wild-type capsids (Fig. 4, left panels). If
there is only onemechanism of UL16 packaging (e.g., through a capsid
interaction), then equal levels of UL16 might be expected in
extracellular UL21-null virions, but this was not the case. Analysis of
3 independent experiments revealed a decrease of 80% (±13%) in the
amount of UL16 packaged into this virus compared to wild-type virus
(Fig. 4, right panels). While this does not prove that multiple
Fig. 4. UL16 is packaged and associates with cytoplasmic capsids in the absence of UL21.
Cytoplasmic capsids from detergent lysed HSV or ΔUL21-infected cells were
sedimented in a 20–50% (wt/vol) sucrose gradient for 1 h. Regions of the gradient
containing capsid bands were isolated with a syringe and then pelleted through a 30%
(wt/vol) sucrose cushion. Virions present in the media were sucrose gradient puriﬁed
as described. Virions and capsids with their associated proteins were separated by SDS–
PAGE in 10% gels and analyzed by immunoblotting with VP5, UL21, and UL16 speciﬁc
antibodies. cyto, cytoplasmic.
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UL21 is somehow critical for efﬁcient incorporation of UL16 into
assembling particles but not for cytoplasmic capsid association.
To test whether the UL11-UL16 interaction is required for the
incorporation of UL16, virus particles lacking the UL11 protein were
puriﬁed from the extracellular media and analyzed for the presence
of UL16 (Baines and Roizman, 1992). The amount of UL16 packaged
into UL11-null virions from three independent experiments was
down 70% (±16%) when compared to WT virus (Fig. 5, virus panels).
These results were expected based on published results with PRV,
which demonstrated a decreased amount of UL16 packaged into
UL11-null virions (Klupp et al., 2005). But, unlike the results
obtained with the UL21-null virus (Fig. 5), a decreased level of
UL16 was also detected on cytoplasmic capsids when normalized for
VP5 levels and compared to WT (72%±7, Fig. 5, cyto. capsids
panels). Since the UL16 expression level was normal in the absence
of UL11 (Fig. 5, cell lysate panels), these results also demonstrate
that the presence of UL16 on the wild-type cytoplasmic capsids is not
an artifact of the detergent lysis conditions used throughout these
studies (i.e., UL16 is not artiﬁcially induced to bind cytoplasmic
capsids).Fig. 5. An interaction with UL11 is not essential for UL16 packaging. WT or ΔUL11
extracellular virus and cytoplasmic capsids were puriﬁed in 20–50% (wt/vol) sucrose
gradients and the region of the gradient containing the virions and capsids were pulled
with a needle syringe and pelleted through a sucrose cushion. Cell lysates, puriﬁed
capsids and virions were then analyzed for the presence of VP5, UL16 and UL11 by
immunoblotting cyto, cytoplasmic.Discussion
The experiments described in this report substantiate the capsid-
loadingmodel, where a population of UL16 is added to capsids prior to
their arrival at the TGN for maturation budding. However, two
observations suggest that UL16 may be loaded onto capsids even as
they are budding into, or exiting from, the nuclear membrane (Fig. 1,
nuclear-loading model). First, the UL11 protein, a binding partner of
UL16, has been shown to be present on nuclear membranes (Loomis
et al., 2001; Baines et al., 1995), raising the possibility that UL16
molecules could be recruited there. Second, a decreased amount of
UL16 was found on cytoplasmic capsids harvested from cells infected
with the UL11-null mutant (this report). Whatever the timing of
addition, interactions of UL16 with tegument proteins UL11 and UL21
are not absolutely required for capsid binding; however, in the
absence of either protein, a severe decrease was observed in the
amount of UL16 packaged into virions.
There are two entirely different – and difﬁcult to resolve –
molecular models that could explain why the packaging levels for
UL16 are reduced in the absence of UL11 or UL21. In the ﬁrst, low
levels of UL16 are added to cytoplasmic capsids but additional
molecules are added at the TGN, where complexes reside that
contain UL11, UL21 and UL16 (Fig. 1, TGN-loading model). In the
second model (not illustrated), all of the UL16 destined for the
virion is loaded onto capsids prior to their reaching the TGN, but an
absence of UL11 at the membrane or UL21 on the capsid eliminates
a regulatory mechanism, causing UL16 to be prematurely destabi-
lized and lost from capsids during budding. Thus, similar to the
construction of a machine, if one component is missing during the
assembly process, then other components may not be held in place
properly during subsequent steps. In support of this regulatory
hypothesis, we recently demonstrated that the UL16–capsid inter-
action is destabilized during capsid egress (Meckes, Jr. and Wills,
2007, 2008). Moreover, extensive studies of PRV have shown that
viruses lacking UL11, UL16 and UL21 contain multiple changes in
their tegument composition (Klupp et al., 2005; Michael et al., 2006,
2007).
Discovering what UL16 is bound to on the capsid would provide
one more piece of this machine that is important for the capsid
release mechanism. It is clear from the data presented here that the
inner tegument proteins UL21, UL36 and UL37 are not required for
UL16 to associate with capsids, although the presence of UL37 may
have a minor role. Since the block in the UL36- and UL37-null
viruses is at the stage of secondary envelopment, at least some UL16
must be added to capsids prior to maturation budding and
subsequent steps in the assembly process may lead to the
destabilization of UL16 on the capsid. These data also suggest a
potential linkage through a tegument/capsid protein other than
UL37 and UL36 or a protein(s) that associates with them. Thus, a
yet-to-be identiﬁed protein must link UL16 to capsids. Recent data
by Lee et al. (2008) may help explain why UL16 still associates with
capsids even in the absence of UL36 or UL37. In their study, the
authors identiﬁed interactions of UL16 with the major capsid
protein (VP5) and a minor capsid protein (VP26) using a yeast
two-hybrid assay (Lee et al., 2008). These potential interactions
have not been conﬁrmed using other methods or demonstrated in
the context of an infection. However, if these interactions do indeed
occur on the capsid during egress, then UL16 would bind directly to
the capsid shell through an interaction with VP26 or VP5. The most
direct way to identify what UL16 is bound to on the capsid would
be through the use of chemical crosslinkers and mass spectrometry.
Additionally, the analysis of UL16 mutants for their ability to bind
and be released from capsids will likely provide valuable informa-
tion into the packaging and release mechanisms.
In summary, the experiments described here provide another
example of a tegument protein that is added to capsids prior to
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2006; Read and Patterson, 2007; Padula et al., 2009). The discovery
that UL11 and UL21 likely participate in additional mechanisms of
UL16 packaging further emphasizes the complex network of
interactions that takes place for the proper construction of the
tegument. Deciphering exactly where each tegument protein is
acquired during egress and which protein interactions are necessary
is critical to obtaining a better understanding of the herpesvirus
assembly process.
Materials and methods
Virus and cells
Vero cells were propagated in Dulbecco'smodiﬁed Eagle's medium
(DMEM; Invitrogen) supplemented with 5% fetal bovine serum (FBS),
5% bovine calf serum (BCS), penicillin and streptomycin (Gibco
15140-148). The KOS strain of HSV-1 used in these studies was grown
in Vero cells with DMEM supplemented with 2% FBS, 25 mM HEPES
buffer, glutamine (0.3 μg/ml), penicillin and streptomycin. The HSV-1
VP23, UL36 and UL37 deletion viruses and complementing cells C32,
HS30 and BD45, respectively, were kindly provided by Prashant Desai
(Johns Hopkins University). The complementing cells were grown in
DMEM supplemented with 1 mg/mL of G418 as previously described
(Desai, 2000; Desai et al., 2001). The gE−/gD− virus and comple-
menting gD expressing cells (VD60) were a gift from David Johnson
(Oregon Health and Science Center) (Farnsworth et al., 2003). The
VD60 cells were maintained in DMEM lacking histadine (Hyclone)
and supplemented with 10% FBS and 1.0 mM histidinol (Sigma
H6647) as described previously (Farnsworth et al., 2003). HSVmutant
viruses containing deletions of UL11, UL21 and UL16 were generous
gifts of Joel Baines (Cornell University) (Baines and Roizman, 1991,
1992; Baines et al., 1994).
Antibodies
UL16, UL11, UL36, gD and VP5-speciﬁc antibodies were produced
in rabbits and have been described previously (Loomis et al., 2001,
2003; McNabb and Courtney, 1992; Baird et al., 2008). Rabbit
polyclonal antibody raised against gE was a kind gift from Harvey
Friedman (University of Pennsylvania) (Saldanha et al., 2000). Rabbit
polyclonal antibody generated against the UL37 protein was gener-
ously provided by Frank Jenkins (University of Pittsburgh) (Schmitz et
al., 1995).
Membrane ﬂoatation assay
Membrane-associated proteins were separated from non-mem-
brane-bound proteins using a previously established protocol
(Brignati et al., 2003; Baird et al., 2008). Brieﬂy, ﬁve conﬂuent
100-mm dishes of HSV-infected or UL16-GFP-transfected Vero cells
were harvested in cold PBS at 20 h post-infection or post-
transfection, respectively. Cells were pelleted at 1000×g for 5 min
at 4 °C, resuspended in hypotonic lysis buffer (10 mM Tris–HCl, pH
7.4, 0.2 mM MgCl2) with protease inhibitors and incubated 30 min
on ice. Following incubation, cells were lysed by dounce homoge-
nization (35 strokes). Unbroken cells and nuclei were pelleted at
1000×g for 10 min at 4 °C. The supernatants (0.3 ml) were mixed
with 2.7 ml of 65% wt/wt sucrose in TNE, placed in the bottom of a
Beckman SW41 Ti tube and sequentially overlayed with 45% (7 ml)
and 2.5% (2 ml) wt/wt sucrose. The resulting sucrose step gradient
was centrifuged at 100,000×g for 18 h at 4 °C in a Beckman SW41
rotor. 800 μl fractions were taken from the top using a piston
gradient fractionator (Brandel). Trichloroacetic acid (TCA) was
added to each fraction at ﬁnal concentration of 13%, and the
samples were incubated overnight at 4 °C. The precipitated proteinswere collected by centrifugation in a microcentrifuge at 18,000×g
for 30 min, washed with 100% ethanol, resuspended in sodium
dodecyl sulfate–polyacrylamide gel electrophoresis (SDS–PAGE)
sample buffer (3.5% SDS, 8.5% β-mercaptoethanol, 130 mM dithio-
threitol, 0.5 M urea, 290 mM Tris–HCl, pH 8.8) and boiled for 15 min
at 95 °C.
To analyze non-membrane-bound capsids, the bottom two
fractions from the sucrose step gradient were combined and treated
with NP-40 (0.5% ﬁnal). Capsids were then pelleted through a 30%wt/
vol sucrose cushion and analyzed by SDS–PAGE and immunoblot.
Capsid analysis
Capsids were harvested from the cytoplasm of infected cells as
previously described (Meckes, Jr. and Wills, 2007). Brieﬂy, twenty
100-mm plates of conﬂuent Vero cells were infected at an MOI of 5. At
20 to 22 h post-infection, cells were scraped into 20 ml of phosphate-
buffered saline (PBS), collected by centrifugation at 1000×g for
10 min, resuspended in 6 ml of NP-40 lysis buffer (0.5% NP-40,
150 mM NaCl, 50 mM Tris–HCl pH 8.0) containing protease inhibitors
(Sigma, P8340) and incubated for 15 min on ice. The cytoplasmic
fractionwas separated from the nuclei by centrifugation at 1000×g for
10 min. Insoluble material from the cytoplasmic fractions was cleared
by centrifugation at 8000×g for 30 min. The capsids remaining in the
soluble supernatant were pelleted through a 1.7-ml 30% (wt/vol in
TNE; 20 mM Tris–HCl pH 7.6, 150 mM NaCl, 1 mM EDTA) sucrose
cushion in an SW41 rotor at 83,500×g for 1 h. Pellets were
resuspended in 500 μl of TNE, sonicated for 2 min at moderate
power, layered onto a 20 to 50% (wt/vol sucrose in TNE) continuous
gradient and centrifuged at 74,000×g for 1 h in an SW41 rotor. The
center fraction (4 mL) of the gradient containing the light scattering
capsid bands was pulled with a needle syringe, diluted with 6 ml of
PBS and re-pelleted through a 30% sucrose cushion to concentrate the
capsids. All centrifugation steps were carried out at 4 °C. The puriﬁed
capsids were dissolved in sodium dodecyl sulfate (SDS)–polyacryl-
amide gel electrophoresis sample buffer (62.5 mM Tris–HCl pH 6.8, 2%
SDS, 5% BME, 50 mM DTT, .0025% bromophenol blue, 10% glycerol)
and boiled for 5 min at 95 °C. Samples were separated in SDS–10%
polyacrylamide gels and electrotransferred to nitrocellulose mem-
branes. The enhanced chemiluminescence (ECL) method of immuno-
blot analysis was performed according to the manufacturer's
instructions (Amersham). Anti-UL16 and anti-VP5 were used as the
primary antibodies at dilutions of 1:3000 and 1:7500 (in 1% nonfat
milk in TBS-T [20 mM Tris pH 7.6, 135 mM NaCl, 0.1% Tween 20]),
respectively.
Analysis of deletion viruses
Due to the inefﬁciency of virus release with UL11- and UL21-null
mutants (Baines and Roizman, 1992; Baines et al., 1994), conﬂuent
monolayers of Vero cells were infected with a low MOI (0.01) and
incubated until complete cytopathic effect was visualized (4–5 days).
Infected cells and media were collected and centrifuged for 5 min at
3828×g. Virions from the extracellular supernatant were then
pelleted through a 30% sucrose cushion in an SW32 rotor for 1 h at
83,500×g. The resulting pellets were resuspended overnight at 4 °C in
TNE, sonicated for three 1min pulses in an ice-water bath at moderate
power and sucrose gradient (20 to 50%) puriﬁed in an SW41 rotor for
1 h at 74,000×g. The region of the gradient containing the virion band
was pulled with a needle syringe (4ml), diluted to 10ml with PBS and
re-pelleted through an additional 30% sucrose cushion in an SW41
rotor. The puriﬁed virus pellets were dissolved in sample buffer and
analyzed by immunoblot as described above. Using densitometry, the
amount of UL16 within virions was normalized to VP5 and
represented as a percentage of WT packaging (also normalized to
VP5).
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